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Abstract Leptin, one of the adipokines, functions as a
hormone and a cytokine. In this investigation, we show
for the first time that leptin, in a concentration-dependent
manner, activates human peripheral blood B cells to
induce secretion of IL-6, IL-10, and TNF-α.L e p t i n
increased B cells expressing CD25 and HLA-DR. Leptin
induces phosphorylation of Janus activation kinase 2
(JAK2), signal transducer and activator of transcription 3
(STAT3), p38 mitogen-activated protein kinase
(p38MAPK), and extracellular signal-regulated kinase
(ERK1/2). Furthermore, leptin-induced cytokine secretion
by B cells was blocked by inhibitors of JAK2, STAT3,
p38MAPK, and ERK1/2. These data demonstrate that
leptin activates human B cells to secrete cytokines via
activation of JAK2/STAT3 and p38MAPK/ERK1/2 sig-
naling pathways, which may contribute to its inflamma-
tory and immunoregulatory properties.
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Introduction
Leptin is a 16-kDa nonglycosylated protein encoded by the
obese (ob) gene, which is located on human chromosome 7
and on mouse chromosome 6. Leptin is synthesized
primarily by the white adipose tissue [1]. Leptin functions
as a hormone and as a cytokine. As a cytokine, it plays an
important role in hematopoiesis, angiogenesis, and innate
and adaptive immunity [1–5]. Leptin belongs to a family of
class I cytokines, which are characterized by a four α-helix
bundles [6]. Increased secretion of leptin is associated with
chronic inflammatory conditions [1]. A role of leptin in
inflammation and autoimmunity is supported by the studies
in Ob/ob mice (leptin deficient). Ob/ob mice have reduced
secretion of IL-2, IFN-γ, TNF, and IL-18 and increased
production of Th2 cytokines (IL-4 and IL-10). Leptin
induces inflammatory cytokines by polarizing Th1 response
(IFN-γ and TNF-α production) and activation of monocyte/
macrophages and dendritic cells [2–7].
In addition to their well-defined role in antibody
production, B cells may also regulate immune responses to
microbes and participate in inflammation through production
of cytokines, chemokines, and growth factors [8–11]. Human
B cells have shown to produce cytokines and chemokines,
which can be categorized as: (a) proinflammatory cytokines,
IL-1, IL-6, TNF-α,a n dL T - α; (b) chemokines MIP-1α,M I P -
1β, MCP-1, IP-10, and IL-8; (c) hematopoietic growth
factors, GM-CSF, G-CSF, and M-CSF, which are also
mediators of inflammation; and (d) immunoregulatory
cytokines, such TGF-β, IL-10, and IL-13 [8, 11]. To the
best of our knowledge, this is the first study to demonstrate
that leptin activates human B cells to induce secretion of
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Materials and Methods
Subjects
Peripheral blood mononuclear cells (MNCs) were isolated
from blood of healthy young subjects by Ficoll–Hypaque
density gradient. Protocol was approved by Human Subject
Committee of the Institution Review Board of the University
of California, Irvine.
Antibodies and Reagents
The following antihuman immunoglobulins were used: CD19
PercP, CD69 FITC, CD86 PE, HLA-DR PerCP, and CD25
APC, all from BD Parmingen (San Jose, CA). B cell
enrichment kit was purchased from Stem cell Technologies
(Vancouver, BC, Canada), and recombinant human leptin
from PeproTech (Rocky Hill, New Jersey). Inhibitors of
p38MAPK (SB203580), ERK 1/2 (U0126), STAT3
(WP1066), and JAK2 (Tyrphostin AG490) were purchased
from Calbiochem (Gibbstown, NJ).
Immunophenotyping
B cells were stained with PerCP-conjugated anti-HLA-DR,
APC-conjugated anti-CD25, FITC-conjugated anti-CD69,
and PE-conjugated anti-CD86. After staining, cells were
washed extensively with phosphate-buffered saline and
analyzed. Flow cytometry was performed using FACScalibur
(Becton-Dickenson,San Jose, CA) equipped with argon ion
laser emitting at 488 nm (for FITC, PE, and PerCP excitation)
and a spatially separate diode laser emitting at 631 nm (for
APC excitation). Forward and side scatters were used to gate
and exclude cellular debris. Ten thousand cells were acquired
and analyzed using Flowjo software (Treestar, Ashland, OR).
Purification of B cells
B lymphocytes were purified by immunomagnetic human B
cell enrichment kit according to manufacturer's instructions
(STEMCELL Technologies, Vancouver, Canada). In brief,
peripheral blood mononuclear cells were suspended at no
more than 1×10
8 cells/ml in PBS containing 2% FBS.
Negative selection cocktail (100 μl/ml) was added and
incubated at room temperature for 15 min. Then, the
magnetic nanoparticles were added at 50 μl/ml cells and
incubated for 10 min. Cells were placed in a 12×75-mm
polystyrene tube at a volume of 2.5 ml/tube and placed into
the magnet for 5 min. The magnet was inverted, and the
supernatant was poured off. The magnetically labeled
unwanted cells remain bound inside the original tube. The
purity of negatively selected cells was assessed by flow
cytometry (>97%) as detected by the presence of CD20.
Furthermore, during the process of purification, B cells
were not activated as determined by the expression of
CD80, CD86, HLA-DR, and CD25 (data not shown).
Measurement of Cytokines
Cytokine secretion was measured by ELISA assay. Purified
B cells were activated by various concentrations of leptin
for 24 h. Supernatants were collected and stored at −20°C
until assayed for detection of cytokines by ELISA (ELISA
kits from BD Pharmingen, San Jose, CA) as per manufac-
turer's protocol.
Western Blotting
Purified B cells were incubated in the presence or absence
of 50 ng/ml of leptin for 10 min, and cells were lysed with
lysis buffer. Aliquots of cell lysates containing 20 μgo f
total protein were resolved by SDS–PAGE and transferred
onto membranes (Millipore, Bedford, MA) by electro-
blotting. The membranes were blocked for 1 h at room
temperature in TBS-T buffer with 5% nonfat dried milk and
incubated with primary antibodies overnight at 4°C. The
blots were washed three times for 20 min with TBS-T
buffer and then incubated with HRP-conjugated secondary
antibodies (1:3,000–1:6,000 dilution) for 1 h at room
temperature. After washing three times for 20 min in
TBS-T buffer, blots were developed using enhanced
chemiluminescence reagents (ECL, Pierce Biotechnology,
Inc., Rockford, IL) and exposed to clear-blue X-Ray film.
Actin was used as a loading control. Bands were scanned,
and volumes were calculated. Quantification was done by a
ratio between STAT-3 or pSTAT-3 and actin, JAK2 or
pJAK2 and actin, pp38MAPK or p38MAP and actin, and
pERK1/2 or ERK1/2 and actin.
Results
Leptin Stimulates Human B Cells to Secrete IL-6, TNF-α,
and IL-10
Since B cells have been shown to secrete proinflammatory
cytokines [8, 9, 11] and leptin induces proinflammatory
cytokine secretion from macrophages and Th1 cells [3, 4],
we investigated whether leptin would also activate B cells
to secrete proinflammatory cytokines. Purified B cells were
cultured in the absence or presence of various concen-
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50 ng, and 100 ng/ml) for 24 h, and supernatants were
collected and analyzed by ELISA assay. Leptin, in a
concentration-dependent manner, induced significant secre-
tion of both TNF-α (Fig. 1a) and IL-6 (Fig. 1b) (p<0.05
to <0.01). B cells produced 10-20 times more IL-6 than
TNF-α. Since IL-10 is secreted as a compensatory anti-
inflammatory cytokine, we also studied the effect of leptin
on IL-10 secretion. Figure 1c shows that leptin, in a
concentration-dependent manner, induced IL-10 secretion
from B cell (p<0.05). However, leptin did not induce
secretion of IL-1β (Fig. 1d). Gabay et al. [12] have also
observed minimal or no effect of leptin on IL-1 production
by macrophages.
Leptin Activates B cells
Leptin activates both Th1 and monocytes and macrophages
[3]. Therefore,weinvestigatedwhether leptinalsoactivates B
cells. Purified B cells were stimulated in the presence or
absence of 50 ng/ml of human recombinant leptin for 24 h.
Cells were washed with PBS supplemented with 2% FBS
(PBS/FCS), stained with CD25, CD69, CD86, and HLA-DR
antibodies and isotype controls, analyzed for activation
markers by multicolor flow cytometry (FACSCalibur) using
Flowjosoftware.Figure2 shows the data from three different
subjects. Leptin increased significantly (P<0.05) proportions
of B cells with expression of CD25 and HLA-DR (Fig. 2a).
However, no significant difference was observed on the
density of any of the activation molecules as determined by
mean flourescence intensity (MFI) on B cells (Fig. 2b).
Leptin Activates B cells to Induce Cytokine Secretion
via JAK2/STAT3 and p38MAPK/ERK1/2 Signaling Pathways
Since leptin induces intracellular signaling via activation of
JAK/STAT, and Ras/Raf signaling pathways [13–22], we
examined the effect of leptin on phosphorylation of JAK2,
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Fig. 1 Leptin stimulates human B cells to secrete IL-6, TNF-α, and
IL-10. B cells were purified from MNCs from healthy young donors
by B cell enrichment kit and incubated with various concentrations of
human recombinant leptin for 24 h, and supernatants were collected
and analyzed by ELISA assay. Figure 1 shows data from three
subjects (mean±SD). Leptin, in a concentration-dependent manner,
induced significant secretion of TNF-α (a), IL-6 (b), and IL-10 (c).
Leptin did not induce secretion of IL-1β (d)
474 J Clin Immunol (2011) 31:472–478STAT3, p38MAPK, and ERK1/2. Leptin induced phos-
phorylation of STAT3 and JAK2 (Fig. 3a), and of
p38MAPK and ERK1/2 (Fig. 3b).
To determine a role of JAK2/STAT3 and p38MAPK and
ERK1/2 in leptin-induced cytokine production, we examined
the effect of inhibitors of JAK2 (Tyrphostin AG490) STAT3
(WP1066), and p38MAPK (SB203580) and of ERK1/2
(U0126) on leptin-induced cytokine secretion. Purified B
cells were incubated with50 ng/ml ofleptin inthe presence or
absence of inhibitors of JAK2, STAT3, p38MAPK, or ERK1/
2 for 24 h, and cytokines were measured in the supernatants
by ELISA assay. Each inhibitor blocked significantly (P<
0.05–P<0.001) leptin-induced secretion of IL-6, TNF-α,a n d
IL-10, though to a variable extent (Fig. 4).
Discussion
Leptin is an adipokine of 16 kDa, and in humans, acts as a
cytokine, which affects thymic homeostasis and promotes
Th1 cytokine secretion and cytokine production [1, 2, 23].
It appears to play a role in inflammation and autoimmunity
[1]. The leptin receptor (Ob-R) is a member of the class I
cytokine receptor family [5, 16, 17, 24], and its mRNA is
alternately spliced resulting in at least six isoforms. All
isoforms share an identical extracellular ligand-binding
domain. However, only the long form (Ob-Rb) appears to
be important in leptin signaling. The Ob-Rb is expressed in
the cells of innate and adaptive immunity [7, 25–28].
Effects of leptin on Tcells and antigen-presenting monocytes/
macrophages and dendritic cells have been investigated [2, 7,
13, 24, 27, 29]; however, effects of leptin on B cells have
not been investigated in detail. In this investigation, we
report that leptin, in a concentration-dependent manner,
activates human B cells to increased production of
proinflammatory IL-6 and TNF-α and anti-inflammatory
IL-10. This is similar to cytokines produced by leptin-
activated T cells and macrophages [1]. However, in B
c e l l s ,l e p t i ni n d u c e st e n f o l dm o r eI L - 1 0a n dt e n f o l dl e s s
TNF-α as compared to that produced by macrophages. We
also show that leptin activates B cells as evidenced by
upregulation of CD25 and HLA-DR.
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Fig. 3 Leptin activates B cells via JAK2, STAT3, ERK1/2, and
p38MAPK. Purified B cells from young healthy subjects were cultures
in the presence or absence of leptin (50 ng/ml) for 10 min. Cell lysates
were prepared, and western blotting was performed using native and
phospho anti-JAK2, anti-STAT3, anti-ERK1/2, and anti-p38 MAPK
antibodies. Actin was used as a loading control. Bands were scanned,
and volumes were calculated by densitometry. Quantification was
performed by a ratio between signaling molecule and actin. Leptin
induced phosphorylation of JAK2 and STAT3 (a), and of p38 MAPK
and ERK1/2 (b)
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Fig. 2 Leptin activates B cells. Purified B cells were stimulated in the
presence or absence of 50 ng/ml of human recombinant leptin for
24 h, and then stained with CD25, and CD69, CD86, and HLA-DR
antibodies and isotype controls, and analyzed by multicolor flow
cytometry. Data are from three different subjects. Leptin increased
significantly (*P<0.05) proportions of B cells with expression of
CD25 and HLA-DR (a). However, no significant difference was
observed on the density of any of the activation molecules as
determined by mean flourescence intensity (MFI) on B cells (b)
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contribute to its immunoregulatory property [18]. Leptin
has been reported to polarized T cells toward Th1 type [7].
Recently, it has been reported that leptin activates dendritic
cells to secrete IL-12, a cytokine that shifts T cells to Th1
phenotype. It has been reported that IL-12 directly
stimulates expression of IL-10 by B cells [30]. Our data
show that leptin may directly induce IL-10 secretion from B
cells without involvement of IL-12.
The Ob-Rb lacks intrinsic tyrosine kinase activity and
uses cytoplasmic JAKs for intracellular signaling [18].
There are four known members of JAK family, which are
widely expressed except JAK3, which is restricted to
hematopoietic cells. However, under physiological condi-
tions, only JAK2 is activated during OB-R signaling [31].
Leptin binding to Ob-Rb leads to formation of a receptor
complex, allowing activation of JAK2 by auto- or cross-
phosphorylation. Activated JAK2 then rapidly phosphor-
ylates several tyrosine residues in the cytoplasmic domain
of Ob-Rb. Phosphorylated tyrosine 1138 provides a dock-
ing site for STAT3 [32]. STAT3 itself is a substrate for
JAK2 and homo- or hetero-dimerization upon phosphory-
lation, translocates to the nucleus, and modulates transcrip-
tion of genes, including cytokine genes. Our study shows
that leptin induces phosphorylation of both JAK2 and
STAT3 in purified B cells, and inhibitors of JAK2
(Tyrphostin A940) and STAT3 (WP1066) blocked leptin-
induced cytokine production, suggesting that leptin induces
cytokine production by B cells via JAK2/STAT3 signaling
pathway. Similar signaling mechanisms have been observed
with activation of mononuclear cells and dendritic cells by
leptin [7, 13].
Leptin also activates Ras/Raf [33, 34] and phosphoinosi-
tide 3 kinase (PI3K) pathways [35–37]. SHIP2 activates the
MERK pathway including ERK1/2 and p38MAPK through
an interaction with the adaptor protein growth factor
receptor bound protein 2 (GRB2). Leptin activates mono-
cytes using the MAPK pathway that activates NF-κB[ 38],
and expansion of regulatory T cells is mediated by ERK1/2
phosphorylation [39]. Leptin enhances TNF-α production in
Kuffer cells via p38 and JNK MAPK [19]. Gao et al. [21]
have reported leptin-induced activation of cyclooxygenase-2
in endometrial cancer cells via both JAK-2/STAT-3 and
MAPK/ERK pathways. Saxena et al. [22]h a v ea l s or e p o r t e d
concomitant activation of the JAK/STAT, PI3K/AKT, and
ERK signaling in leptin-mediated promotion of invasion and
migration of hepatocellular carcinoma cells. In the present
study, we show that leptin induces phosphorylation of
ERK1/2 and p38MAPK in purified B cells, and leptin-
induced cytokine production was blocked by inhibitors of
both ERK1/2 and p38MAPK, suggesting that Ras/Raf
signaling pathway is involved in leptin-induced cytokine
secretion by human B cells.
In summary, leptin activates human B cells to induce
synthesis and secretion of cytokines, which is mediated via
both JAK-2/STAT3 and MAPK/ERK signaling pathways.
Therefore, B cells in addition to their well-established
function in adaptive immunity appear to play a role in innate
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Fig. 4 InhibitorsofJAK2/STAT3,
p38MAPK, and ERK1/2 inhibit
leptin-induced secretion of
cytokines. Purified B cells were
i n c u b a t e dw i t h5 0n g / m lo fl e p t i n
in the presence or absence of
inhibitors of ERK1/2 (12.5 μM
U0126), JAK2 (25 μM
Tyrphostin AG490), STAT3
(WP1066), or p38MAPK inhibitor
(1 μM SB203580) for 24 h, and
cytokines were measured in the
supernatantsbyELISA assay.Each
inhibitor significantly blocked
leptin-induced secretion of IL-6,
TNF-α, and IL-10 (*=P<0.05,
**P<0.001)
476 J Clin Immunol (2011) 31:472–478immunity, and leptin via activation of B cells and induction of
cytokine secretion may play a role in inflammation and
immunoregulation.
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